Ørskov et al., 1987 - Google Patents
Pancreatic and intestinal processing of proglucagon in manØrskov et al., 1987
View PDF- Document ID
- 3152292174243769436
- Author
- Ørskov C
- Holst J
- Poulsen S
- Kirkegaard P
- Publication year
- Publication venue
- Diabetologia
External Links
Snippet
We developed antisera and radioimmunoassays against synthetic replicas of glucagon-like peptide-1 (1–36) and-2, predicted products of the glucagon precursor, and against glucagon- like peptide-1 (7–36) identical to the sequence of glucagon-like peptide-1, but lacking its first …
- 230000000968 intestinal 0 title abstract description 6
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones; against hormone releasing or inhibiting factors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ørskov et al. | Pancreatic and intestinal processing of proglucagon in man | |
ØRSKOV et al. | Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas | |
Itoh et al. | Functional receptors for fish neuropeptide urotensin II in major rat arteries | |
SHIMIZU et al. | Identification and localization of glucagon-like peptide-1 and its receptor in rat brain | |
Gros et al. | Glucagon-like peptide-1-(7-36) amide, oxyntomodulin, and glucagon interact with a common receptor in a somatostatin-secreting cell line | |
EP0512042B1 (en) | Glp-1 analogs useful for diabetes treatment | |
Orskov et al. | Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. | |
US5545618A (en) | GLP-1 analogs useful for diabetes treatment | |
Sasaki et al. | Identification of glucagon in the gastrointestinal tract. | |
Chang et al. | Radioimmunoassay of cholecystokinin | |
Baldissera et al. | Oxyntomodulin (glicentin-(33–69)): pharmacokinetics, binding to liver cell membranes, effects on isolated perfused pig pancreas, and secretion from isolated perfused lower small intestine of pigs | |
Kervran et al. | Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat | |
George et al. | Molecular forms of glucagon‐like peptides in man | |
Kimmel et al. | Structure of a peptide from coho salmon endocrine pancreas with homology to neuropeptide Y | |
Gutkowska | Radioimmunoassay for atrial natriuretic factor | |
Itoh et al. | Radioimmunoassay for brain natriuretic peptide (BNP) detection of BNP in canine brain | |
Rehfeld et al. | Identification of gastrin component I as gastrin‐71: The largest possible bioactive progastrin product | |
Yandle et al. | Amino acid sequence of atrial natriuretic peptides in human coronary sinus plasma | |
Ghatei et al. | Molecular forms of glucagon-like immunoreactivity in porcine intestine and pancreas | |
Macaulay Hunter et al. | Analysis of peptides derived from pro atrial natriuretic peptide that circulate in man and increase in heart disease | |
Lee et al. | Man and Its Chromatographic Characterization in Human Plasma | |
Suess et al. | Radioimmunoassays for fish tail neuropeptides: I. Development of assay and measurement of immunoreactive urotensin I in Catostomus commersoni brain, pituitary, and plasma | |
THOMPSON et al. | Monoiodo-oxytocin: demonstration of its biological activity and specific binding to isolated fat cells | |
Eysselein et al. | Structural characterization of canine PYY | |
Kuwasako et al. | Increased plasma proadrenomedullin N-terminal 20 peptide in patients with essential hypertension |